On this page you will find our recommendations sorted by BNF chapter.

Appraisal Reports are available to stakeholders on request.

Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on nuth.nyrdtc.rxsupp@nhs.net

Title Documents Decision Date
Left atrial appendage occlusion devices for stroke prevention in patients with non-valvular atrial fibrillation (NETAG) Recommendation Recommended for patients with a proven bleeding risk which contraindicates anticoagulation therapy 10/07/2012
Stand-alone minimally invasive bipolar radiofrequency ablation for Atrial Fibrillation (NETAG) Recommendation Recommended for atrial fibrillation where catheter ablation is not suitable due to clinical, technical or anatomical reasons 12/07/2011
Top Tips and Recommendations for Sodium Glucose Co-transporter 2 inhibitors (SGLT2i) in HFrEF SGLT2 in Heart Failure Top Tips NTAG v1 - approved June 2022 Approved by NTAG 07/06/2022
NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF NENC Decision Aid incl Table to support decison of DOAC in AF - approved June 2022 - final Approved by NTAG 07/06/2022


Northern England Evaluation and Lipid Intensification guideline NEELI edit v2022.2-FINAL-NTAG Approved by NTAG 06/09/2022